Drawing for ESLATAM

USPTO serial 85520167

ESLATAM

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
TRUSILO, KELLY JEAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ESLATAM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Bevilacqua, Esquire

Michael J. Bevilacqua, Esquire Wilmer Cutler Pickering Hale and DorrLLP60 State StreetBoston, MA 02109UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances, namely, analgesics; anti-infectives; anti-inflammatories; pharmaceutical products and preparations, namely, products for the treatment of epilepsy, neuropathic pain, and bipolar disorder; anti-epileptic drugs; pharmaceutical products, preparations and substances for the prevention and treatment of disorders and diseases of the central nervous system, peripheral nervous system, respiratory system, urogenital system, cardiovascular system, endocrine system, metabolic system, renal system, gastroenterologic system, ophthalmologic system, and dermatologic system; pharmaceutical preparations and substances for the prevention and treatment of hematologic and oncologic disorders and diseases, psychiatric disorders and diseases, allergic disorders and diseases and disorders and diseases of the immune system, connective tissue and joints; and pharmaceutical preparations and substances for the prevention and treatment of insomnia and other sleep related diseases and disorders; pharmaceutical preparations for the prevention and treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 8, 2015MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 7, 2015ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 12, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 11, 2015EX5GSOU EXTENSION 5 GRANTED—
Feb 5, 2015EXT5SOU EXTENSION 5 FILED—
Feb 5, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 23, 2014DOCKASSIGNED TO EXAMINER—
Aug 15, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 14, 2014EX4GSOU EXTENSION 4 GRANTED—
Aug 7, 2014EXT4SOU EXTENSION 4 FILED—
Aug 7, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 27, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 26, 2014EX3GSOU EXTENSION 3 GRANTED—
Feb 7, 2014EXT3SOU EXTENSION 3 FILED—
Feb 7, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 31, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 30, 2013EX2GSOU EXTENSION 2 GRANTED—
Aug 7, 2013EXT2SOU EXTENSION 2 FILED—
Aug 7, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 21, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 20, 2013EX1GSOU EXTENSION 1 GRANTED—
Feb 20, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 7, 2013EXT1SOU EXTENSION 1 FILED—
Feb 7, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 7, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 6, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 6, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 12, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 12, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 23, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 10, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 9, 2012ALIEASSIGNED TO LIE—
Apr 24, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 23, 2012DOCKASSIGNED TO EXAMINER—
Jan 24, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 23, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance